Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
Auteurs Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
Auteurs (entité) FLAMEN PATRICK
Revue Eur J Nucl Med Mol Imaging
Date de publication 2025-08

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
Auteurs Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
Auteurs (entité) WOFF ERWIN
Revue Eur J Nucl Med Mol Imaging
Date de publication 2025-08

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) DE AZAMBUJA EVANDRO
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) BUISSERET LAURENCE
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) DE CALUWE ALEX
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) BUISSERET LAURENCE
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) SOTIRIOU CHRISTOS
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) MAJJAJ SAMIRA
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.
Auteurs Meyers M, Paesmans M, Fleur W, Libert I, Klášterský J
Auteurs (entité) KLASTERSKY JEAN
Revue Support Care Cancer
Date de publication 2025-08

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.

Erasme hospital

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus

Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet